PTGS2 and colorectal carcinoma: Interestingly, some studies reported that a urinary prostaglandin metabolite PGE-M might be an interesting CRC biomarker because PGE-M plays an important role in the regulation of cyclooxygenase-2 effects in CRC and elevated levels of PGE-M is associated with advanced adenomas and increased risk of CRC (97).